Abiopharma

🔍 Davis Tahnil R. (Executive)

Company: Trade Desk, Inc. (TTD)

Report Date: 2026-08-15

Detailed Transactions and Holdings:

• Sold 1,220 shares of Class A Common Stock at $14.14 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 250,449.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,051 shares of Class A Common Stock at $14.14 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 249,398.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,373 shares of Class A Common Stock at $14.14 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 248,025.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 5,317 shares of Class A Common Stock at $14.14 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 242,708.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: The shares were withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of a Restricted Stock Unit Award granted April 24, 2023.
• F2: The shares were withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of a Restricted Stock Unit Award granted April 23, 2024.
• F3: The shares were withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of a Restricted Stock Unit Award granted April 15, 2025.
• F4: The shares were withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of a Restricted Stock Award granted March 3, 2026.